135 related articles for article (PubMed ID: 1768385)
1. The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV.
Rarick MU; Espina B; Montgomery T; Easley A; Allen J; Levine AM
AIDS; 1991 Nov; 5(11):1357-61. PubMed ID: 1768385
[TBL] [Abstract][Full Text] [Related]
2. Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
Peña JM; Arnalich F; Barbado FJ; Dominguez A; Mostaza J; Valencia ME; Vazquez JJ
Acta Haematol; 1990; 83(2):86-8. PubMed ID: 2106201
[TBL] [Abstract][Full Text] [Related]
3. HIV-seropositive thrombocytopenia: the action of zidovudine.
Boyar A; Beall G
AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
Landonio G; Cinque P; Nosari A; Gafa S; Rizzo F; Coen M; Tirelli U; Caggese L; di Luzio Paparatti U; Lazzarin A
AIDS; 1993 Feb; 7(2):209-12. PubMed ID: 8466682
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.
Ballem PJ; Belzberg A; Devine DV; Lyster D; Spruston B; Chambers H; Doubroff P; Mikulash K
N Engl J Med; 1992 Dec; 327(25):1779-84. PubMed ID: 1435932
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
Cinque P; Landonio G; Lazzarin A; Nosari AM; Ruggieri A; Coen M; Meraviglia P; Gringeri A; Gallo L; Quirino T
Eur J Haematol; 1993 Jan; 50(1):17-21. PubMed ID: 8094675
[TBL] [Abstract][Full Text] [Related]
7. The effect of zidovudine on platelet count in HIV-infected individuals.
Montaner JS; Le T; Fanning M; Gelmon K; Tsoukas C; Falutz J; O'Shaughnessy M; Wainberg MA; Ruedy J
J Acquir Immune Defic Syndr (1988); 1990; 3(6):565-70. PubMed ID: 2187071
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
Ann Intern Med; 1988 Nov; 109(9):718-21. PubMed ID: 3190058
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.
Marroni M; Gresele P; Landonio G; Lazzarin A; Coen M; Vezza R; Sinnone MS; Boschetti E; Nosari AM; Stagni G; Nenci GG; Pauluzzi S
Ann Intern Med; 1994 Sep; 121(6):423-9. PubMed ID: 8053616
[TBL] [Abstract][Full Text] [Related]
10. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
Carbonara S; Fiorentino G; Serio G; Maggi P; Ingravallo G; Monno L; Bruno F; Coppola S; Pastore G; Angarano G
J Infect; 2001 May; 42(4):251-6. PubMed ID: 11545567
[TBL] [Abstract][Full Text] [Related]
11. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine.
Pottage JC; Benson CA; Spear JB; Landay AL; Kessler HA
JAMA; 1988 Nov; 260(20):3045-8. PubMed ID: 2972851
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of refractory HIV-related immune thrombocytopenia in a patient with haemophilia A.
Fabris F; Mares M; Sartori MT; Cordiano I; Girolami A
Haematologica; 1992; 77(1):79-81. PubMed ID: 1398285
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations.
Rigaud M; Leibovitz E; Quee CS; Kaul A; Nardi M; Pollack H; Lawrence R; DiJohn D; Krasinski K; Karpatkin M
J Acquir Immune Defic Syndr (1988); 1992; 5(5):450-5. PubMed ID: 1560341
[TBL] [Abstract][Full Text] [Related]
15. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection.
Arranz Caso JA; Sanchez Mingo C; Garcia Tena J
N Engl J Med; 1999 Oct; 341(16):1239-40. PubMed ID: 10523161
[No Abstract] [Full Text] [Related]
16. Zidovudine therapy in HIV-related thrombocytopenia.
Kwiatek RA; Benson EM; Elliott PJ
Aust N Z J Med; 1989 Oct; 19(5):514-5. PubMed ID: 2590108
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia.
Rarick MU; Montgomery T; Groshen S; Sullivan-Halley J; Jamin D; Mazumder A; Gill PS; Loureiro C; Levine AM
Am J Hematol; 1991 Dec; 38(4):261-6. PubMed ID: 1746533
[TBL] [Abstract][Full Text] [Related]
18. No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia.
Galli M; Musicco M; Gervasoni C; Ridolfo AL; Niero F; Rusconi S; Riva A; Voltolin L; Lupo A; Lovicu GF; Radice D; Moroni M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):268-75. PubMed ID: 8673530
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of HIV-1-related, zidovudine resistant, thrombocytopenia with didanosine.
Nasti G; Errante D; Tirelli U
Am J Hematol; 1997 Jun; 55(2):118-9. PubMed ID: 9209010
[No Abstract] [Full Text] [Related]
20. HIV-related thrombocytopenia: is zidovudine a therapeutic option?
Nathwani D; Green ST; Kennedy DH; Love WC; Goldberg D; Fallon RJ
J Infect; 1989 Nov; 19(3):288-90. PubMed ID: 2600447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
